These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3991774)

  • 41. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding.
    Levine AS; Grace M; Billington CJ
    Brain Res; 1991 Oct; 562(2):281-4. PubMed ID: 1663414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN; Das S; Gulati A
    J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The opioid antagonist, MR2266, specifically decreases saline intake in the mouse.
    Ukai M; Nakayama S; Kameyama T
    Neuropharmacology; 1988 Oct; 27(10):1027-31. PubMed ID: 3237313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
    Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electroacupuncture analgesia is mediated by stereospecific opiate receptors and is reversed by antagonists of type I receptors.
    Cheng RS; Pomeranz BH
    Life Sci; 1980 Feb; 26(8):631-8. PubMed ID: 6247596
    [No Abstract]   [Full Text] [Related]  

  • 48. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats.
    Kanarek RB; Mathes WF; Heisler LK; Lima RP; Monfared LS
    Pharmacol Biochem Behav; 1997; 57(1-2):377-81. PubMed ID: 9164597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats.
    Alberti I; Fernández B; Alguacil LF; Aguilar A; Caamaño M; Romero EM; Viveros MP
    Br J Pharmacol; 1999 Nov; 128(5):953-60. PubMed ID: 10556931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
    Häggkvist J; Lindholm S; Franck J
    Behav Brain Res; 2009 Jan; 197(1):219-24. PubMed ID: 18793682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor.
    Arjune D; Bowen WD; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Jun; 39(2):429-36. PubMed ID: 1658817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
    Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
    Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats.
    Znamensky V; Echo JA; Lamonte N; Christian G; Ragnauth A; Bodnar RJ
    Brain Res; 2001 Jul; 906(1-2):84-91. PubMed ID: 11430864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Jan; 782(1-2):18-23. PubMed ID: 9519245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereospecific aversive property of narcotic antagonists in morphine-free rats.
    Stolerman IP; Pilcher CW; D'Mello GD
    Life Sci; 1978 May; 22(19):1755-62. PubMed ID: 672425
    [No Abstract]   [Full Text] [Related]  

  • 59. Ethylketocyclazocine and bremazocine analgesia in neonatal rats.
    Helmstetter FJ; Calcagnetti DJ; Cramer CP; Fanselow MS
    Pharmacol Biochem Behav; 1988 Aug; 30(4):817-21. PubMed ID: 3067243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.
    Naidu PS; Lichtman AH; Archer CC; May EL; Harris LS; Aceto MD
    Eur J Pharmacol; 2007 Jul; 566(1-3):132-6. PubMed ID: 17459369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.